|
|
Innovators |
|
APIs & advance intermediates. Custom synthesis for clinical trial compounds.
Process optimization |
| |
|
Generics
|
|
APIs & advance intermediates.Scale-up & Custom synthesis.
Process optimization
|
| |
|
CRO
|
|
Scale-up for clinical trial requirements (Phase I,II & III & Commercialization)
|
| |
|
CMO
|
|
Utilization of Vedants production capacity. Custom synthesis
|
|
How vedants makes portfolio sense?
|
|
Cost efficiency
|
|
Elimination of time and risk of investment
|
|
Capitalize on potentially valuable resource
|
|
Control over projects
|
|
Protection of IP |
|
Reduction of Time-To market the product
|
|
Exclusivity and No compete agreements
|
|
|
|
